Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, efficacy, and pharmacokinetics of daptomycin (MK-3009) in Japanese pediatric patients with complicated skin and soft tissue infe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Skin and Soft Tissue Infections

Drugs mentioned

• Daptomycin (daptomycin)
• MK-3009

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Bacteremia, Soft Tissue Infections | Phase 2 | Status: COMPLETED | Results posted: 2021-03-30